Global Bio & Investment Monthly

Global Bio & Investment Monthly, also known as GBI Monthly in Taiwan, is a professional media platform focusing on biotechnology, pharmaceutical and healthcare industry. GBI Monthly is the only existing and longest-running paper magazine focusing on the Chinese biomedical industry. As the most influential and informative professional media in the field, it covers a wide range of biomedical topics published by a team of experts with independent editorial and production capabilities. GBI also provides a precise online directory of biomedical vendors. With a deep involvement in the industry and excellent interaction, GBI has become the first choice for media cooperation among governments, research institutions, industry organizations, and medical systems. It has an extremely rich database of industry news and conducts various biomedical industry surveys, covering advanced biotechnology, pharmaceuticals, medical devices, life sciences, capital investment, industry policies, and more. GBI is an important portal and information platform for the Taiwan biomedical industry, connecting local and international networks. Currently, GBI is expanding its reach on various high-impact biomedical topics, developing multilingual services, connecting with international biomedical media, and collaborating with asset valuation agencies. It continues to conduct deep industry research and analysis and provide detailed reports to support stakeholders in making informed decisions. Media features 1. Dimensions ：21.5 * 28 cm 2. Date of issue：Daily(Online), Monthly(Print) 3. Target Audience：Professionals in biotechnology, healthcare, pharmaceutical, investment corporations and institutions